Nutra Pharma Announces First Manufacturing Agreement
23 mars 2022 09h15 HE
|
Nutra Pharma Corp.
Plantation, Florida, March 23, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in...
Nutra Pharma Expands Manufacturing Capabilities
17 mars 2022 09h15 HE
|
Nutra Pharma Corp.
Plantation, Florida, March 17, 2022 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in...
Nutra Pharma Provides Sales and Marketing Update
20 déc. 2012 14h27 HE
|
Nutra Pharma Corporation
Nutra Pharma is providing an update on the sales and marketing efforts of TCN as they begin their global marketing campaign for Nutra Pharma's over-the-counter (OTC) pain reliever,...
Nutra Pharma Introduces Nyloxin(TM) Military Strength
19 déc. 2012 09h15 HE
|
Nutra Pharma Corporation
CORAL SPRINGS, Fla., Dec. 19, 2012 (GLOBE NEWSWIRE) -- Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple...
Nutra Pharma Letter to Shareholders
18 déc. 2012 09h43 HE
|
Nutra Pharma Corporation
CORAL SPRINGS, Fla., Dec. 18, 2012 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTCQB:NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...
Nutra Pharma Begins Affiliate Sales & Marketing Program for the Distribution of Nyloxin(TM)
02 mai 2012 09h18 HE
|
Nutra Pharma Corporation
CORAL SPRINGS, Fla., May 2, 2012 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTCBB:NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...